Search Results - "Pasquevich, Karina"
-
1
Safety and immunogenicity of a SARS-CoV-2 Gamma variant RBD-based protein adjuvanted vaccine used as booster in healthy adults
Published in Nature communications (28-07-2023)“…A Gamma Variant RBD-based aluminum hydroxide adjuvanted vaccine called ARVAC CG was selected for a first in human clinical trial. Healthy male and female…”
Get full text
Journal Article -
2
Systemic bacterial infections affect dendritic cell development and function
Published in International journal of medical microbiology (01-08-2021)“…Dendritic cells (DCs) are critical in host defense against infection. DC depletion is an early event in the course of sepsis that may impair the host defense…”
Get full text
Journal Article -
3
An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice
Published in PloS one (14-01-2011)“…As Brucella infections occur mainly through mucosal surfaces, the development of mucosal administered vaccines could be radical for the control of brucellosis…”
Get full text
Journal Article -
4
U-Omp19 from Brucella abortus increases dmLT immunogenicity and improves protection against Escherichia coli heat-labile toxin (LT) oral challenge
Published in Vaccine (06-07-2020)“…•Oral co-administration of dmLT with U-Omp19 increases dmLT immunogenicity.•U-Omp19 oral co-delivery with dmLT induces anti-LT antibody responses.•U-Omp19…”
Get full text
Journal Article -
5
A Gamma-adapted subunit vaccine induces broadly neutralizing antibodies against SARS-CoV-2 variants and protects mice from infection
Published in Nature communications (02-02-2024)“…In the context of continuous emergence of SARS-CoV-2 variants of concern (VOCs), one strategy to prevent the severe outcomes of COVID-19 is developing safe and…”
Get full text
Journal Article -
6
Oral co-administration of a bacterial protease inhibitor in the vaccine formulation increases antigen delivery at the intestinal epithelial barrier
Published in Journal of controlled release (10-01-2019)“…The study of capture and processing of antigens (Ags) by intestinal epithelial cells is very important for development of new oral administration systems…”
Get full text
Journal Article -
7
A Novel Bacterial Protease Inhibitor Adjuvant in RBD-Based COVID-19 Vaccine Formulations Containing Alum Increases Neutralizing Antibodies, Specific Germinal Center B Cells and Confers Protection Against SARS-CoV-2 Infection in Mice
Published in Frontiers in immunology (28-02-2022)“…In this work, we evaluated recombinant receptor binding domain (RBD)-based vaccine formulation prototypes with potential for further clinical development. We…”
Get full text
Journal Article -
8
Immunization with Recombinant Brucella Species Outer Membrane Protein Omp16 or Omp19 in Adjuvant Induces Specific CD4⁺ and CD8⁺ T Cells as Well as Systemic and Oral Protection against Brucella abortus Infection
Published in Infection and Immunity (01-01-2009)“…Available vaccines against Brucella spp. are live attenuated Brucella strains. In order to engineer a better vaccine to be used in animals and humans, our…”
Get full text
Journal Article -
9
Depletion of dendritic cells enhances innate anti-bacterial host defense through modulation of phagocyte homeostasis
Published in PLoS pathogens (01-02-2012)“…Dendritic cells (DCs) as professional antigen-presenting cells play an important role in the initiation and modulation of the adaptive immune response…”
Get full text
Journal Article -
10
Omp19 Enables Brucella abortus to Evade the Antimicrobial Activity From Host's Proteolytic Defense System
Published in Frontiers in immunology (26-06-2019)“…Pathogenic microorganisms confront several proteolytic events in the molecular interplay with their host, highlighting that proteolysis and its regulation play…”
Get full text
Journal Article -
11
A Brucella spp. Protease Inhibitor Limits Antigen Lysosomal Proteolysis, Increases Cross-Presentation, and Enhances CD8+ T Cell Responses
Published in The Journal of immunology (1950) (15-05-2016)“…In this study, we demonstrate that the unlipidated (U) outer membrane protein (Omp) 19 from Brucella spp. is a competitive inhibitor of human cathepsin L…”
Get full text
Journal Article -
12
RomA, A Periplasmic Protein Involved in the Synthesis of the Lipopolysaccharide, Tunes Down the Inflammatory Response Triggered by Brucella
Published in The Journal of infectious diseases (28-03-2018)“…Abstract Brucellaceae are stealthy pathogens with the ability to survive and replicate in the host in the context of a strong immune response. This capacity…”
Get full text
Journal Article -
13
Unlipidated outer membrane protein Omp16 (U-Omp16) from Brucella spp. as nasal adjuvant induces a Th1 immune response and modulates the Th2 allergic response to cow's milk proteins
Published in PloS one (05-07-2013)“…The discovery of novel mucosal adjuvants will help to develop new formulations to control infectious and allergic diseases. In this work we demonstrate that…”
Get full text
Journal Article -
14
Innate immune system favors emergency monopoiesis at the expense of DC‐differentiation to control systemic bacterial infection in mice
Published in European journal of immunology (01-10-2015)“…DCs are professional APCs playing a crucial role in the initiation of T‐cell responses to combat infection. However, systemic bacterial infection with various…”
Get full text
Journal Article -
15
The protein moiety of Brucella abortus outer membrane protein 16 is a new bacterial pathogen-associated molecular pattern that activates dendritic cells in vivo, induces a Th1 immune response, and is a promising self-adjuvanting vaccine against systemic and oral acquired brucellosis
Published in The Journal of immunology (1950) (01-05-2010)“…Knowing the inherent stimulatory properties of the lipid moiety of bacterial lipoproteins, we first hypothesized that Brucella abortus outer membrane protein…”
Get full text
Journal Article -
16
U-Omp19 from Brucella abortus Is a Useful Adjuvant for Vaccine Formulations against Salmonella Infection in Mice
Published in Frontiers in immunology (17-02-2017)“…Most pathogens infect through mucosal surfaces, and parenteral immunization typically fails to induce effective immune responses at these sites. Development of…”
Get full text
Journal Article -
17
A bacterial protease inhibitor protects antigens delivered in oral vaccines from digestion while triggering specific mucosal immune responses
Published in Journal of controlled release (28-12-2015)“…We report here that a bacterial protease inhibitor from Brucella spp. called U-Omp19 behaves as an ideal constituent for a vaccine formulation against…”
Get full text
Journal Article -
18
Brucella abortus Induces the Secretion of Proinflammatory Mediators from Glial Cells Leading to Astrocyte Apoptosis
Published in The American journal of pathology (01-03-2010)“…Central nervous system (CNS) invasion by bacteria of the genus Brucella results in an inflammatory disorder called neurobrucellosis. In this study we present…”
Get full text
Journal Article -
19
A disordered region retains the full protease inhibitor activity and the capacity to induce CD8+ T cells in vivo of the oral vaccine adjuvant U-Omp19
Published in Computational and structural biotechnology journal (2022)“…[Display omitted] U-Omp19 is a bacterial protease inhibitor from Brucella abortus that inhibits gastrointestinal and lysosomal proteases, enhancing the…”
Get full text
Journal Article -
20
Brucella abortus Omp19 recombinant protein subcutaneously co-delivered with an antigen enhances antigen-specific T helper 1 memory responses and induces protection against parasite challenge
Published in Vaccine (20-01-2016)“…Abstract The discovery of effective adjuvants for many vaccines especially those with limited commercial appeal, such as vaccines to poverty-related diseases,…”
Get full text
Journal Article